BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36697102)

  • 1. Glasgow Prognostic Score Predicts Survival and Recurrence Pattern in Patients With Hepatocellular Carcinoma After Hepatectomy.
    Kumamoto T; Takeda K; Matsuyama R; Sawada YU; Sahara K; Yabushita Y; Homma Y; Watanabe J; Numata M; Sato T; Morioka D; Kunisaki C; Endo I
    Anticancer Res; 2023 Feb; 43(2):875-882. PubMed ID: 36697102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glasgow prognostic score predicts therapeutic outcome after hepatic resection for hepatocellular carcinoma.
    Shiba H; Horiuchi T; Sakamoto T; Furukawa K; Shirai Y; Iida T; Fujiwara Y; Haruki K; Yanaga K
    Oncol Lett; 2017 Jul; 14(1):293-298. PubMed ID: 28693167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma.
    Abe T; Tashiro H; Kobayashi T; Hattori M; Kuroda S; Ohdan H
    World J Surg; 2017 Jul; 41(7):1860-1870. PubMed ID: 28197709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glasgow prognostic score predicts outcome after surgical resection of gallbladder cancer.
    Shiba H; Misawa T; Fujiwara Y; Futagawa Y; Furukawa K; Haruki K; Iwase R; Iida T; Yanaga K
    World J Surg; 2015 Mar; 39(3):753-8. PubMed ID: 25348884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative C-reactive protein/albumin ratio to predict mortality and recurrence of patients with hepatocellular carcinoma after curative resection.
    Ren Y; Fan X; Chen G; Zhou D; Lin H; Cai X
    Med Clin (Barc); 2019 Sep; 153(5):183-190. PubMed ID: 30606506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glasgow Prognostic Score as a useful prognostic factor after hepatectomy for hepatocellular carcinoma.
    Horino K; Beppu T; Kuroki H; Mima K; Okabe H; Nakahara O; Ikuta Y; Chikamoto A; Ishiko T; Takamori H; Baba H
    Int J Clin Oncol; 2013 Oct; 18(5):829-38. PubMed ID: 22821222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of preoperative inflammation-based score for the prognosis of patients with hepatocellular carcinoma who underwent hepatectomy.
    Matsumoto T; Kitano Y; Imai K; Kinoshita S; Sato H; Shiraishi Y; Mima K; Hayashi H; Yamashita YI; Baba H
    Surg Today; 2022 Jul; 52(7):1008-1015. PubMed ID: 35083547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Glasgow Prognostic Score is an independent prognostic predictor of hepatocellular carcinoma following radical resection.
    Pan QX; Zhang JH; Su ZJ; Wang CR; Ke SY
    Oncol Res Treat; 2014; 37(4):192-7. PubMed ID: 24732643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.
    Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M
    Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New prognostic system based on inflammation and liver function predicts prognosis in patients with advanced unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A validation study.
    Tada T; Kumada T; Hiraoka A; Kariyama K; Tani J; Hirooka M; Takaguchi K; Atsukawa M; Fukunishi S; Itobayashi E; Tsuji K; Tajiri K; Ochi H; Ishikawa T; Yasuda S; Ogawa C; Toyoda H; Hatanaka T; Nishimura T; Kakizaki S; Kawata K; Shimada N; Tada F; Nouso K; Tsutsui A; Ohama H; Morishita A; Nagano T; Itokawa N; Okubo T; Arai T; Kosaka H; Imai M; Naganuma A; Nakamura S; Koizumi Y; Kaibori M; Iijima H; Hiasa Y;
    Cancer Med; 2023 Mar; 12(6):6980-6993. PubMed ID: 36484470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative peak serum C-reactive protein predicts outcome of hepatic resection for hepatocellular carcinoma.
    Shiba H; Furukawa K; Fujiwara Y; Futagawa Y; Haruki K; Wakiyama S; Ishida Y; Misawa T; Yanaga K
    Anticancer Res; 2013 Feb; 33(2):705-9. PubMed ID: 23393371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multi-institutional Study.
    Harimoto N; Yoshizumi T; Inokuchi S; Itoh S; Adachi E; Ikeda Y; Uchiyama H; Utsunomiya T; Kajiyama K; Kimura K; Kishihara F; Sugimachi K; Tsujita E; Ninomiya M; Fukuzawa K; Maeda T; Shirabe K; Maehara Y
    Ann Surg Oncol; 2018 Oct; 25(11):3316-3323. PubMed ID: 30051372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothrombin induced by vitamin K Absence-II versus alpha-fetoprotein in detection of both resectable hepatocellular carcinoma and early recurrence after curative liver resection: A retrospective cohort study.
    Wang MD; Sun LY; Qian GJ; Li C; Gu LH; Yao LQ; Diao YK; Pawlik TM; Lau WY; Huang DS; Shen F; Yang T
    Int J Surg; 2022 Sep; 105():106843. PubMed ID: 35995351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma.
    Hashimoto K; Ikeda Y; Korenaga D; Tanoue K; Hamatake M; Kawasaki K; Yamaoka T; Iwatani Y; Akazawa K; Takenaka K
    Cancer; 2005 May; 103(9):1856-64. PubMed ID: 15779015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
    Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
    Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prognostic Value of Preoperative Serum Markers and Risk Classification in Patients with Hepatocellular Carcinoma.
    Ota M; Komeda K; Iida H; Ueno M; Kosaka H; Nomi T; Tanaka S; Nakai T; Hokutou D; Matsumoto M; Hirokawa F; Lee SW; Kaibori M; Kubo S
    Ann Surg Oncol; 2023 May; 30(5):2807-2815. PubMed ID: 36641514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of the Glasgow Prognostic Score for patients with metastatic renal cell carcinoma treated by cytoreductive nephrectomy.
    Fukuda H; Takagi T; Kondo T; Yoshida K; Shimizu S; Nagashima Y; Tanabe K
    Int J Clin Oncol; 2018 Jun; 23(3):539-546. PubMed ID: 29302841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glasgow prognostic score predicts therapeutic outcome after pancreaticoduodenectomy for carcinoma of the ampulla of vater.
    Shiba H; Misawa T; Fujiwara Y; Futagawa Y; Furukawa K; Haruki K; Iwase R; Wakiyama S; Ishida Y; Yanaga K
    Anticancer Res; 2013 Jun; 33(6):2715-21. PubMed ID: 23749931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein induced by vitamin K antagonist-II (PIVKA-II) is a reliable prognostic factor in small hepatocellular carcinoma.
    Kim JM; Hyuck C; Kwon D; Joh JW; Lee JH; Paik SW; Park CK
    World J Surg; 2013 Jun; 37(6):1371-8. PubMed ID: 23443153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.